Peter E. Clayton

发表

Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1

P. Clayton, C. Beesley, B. Winchester, 2000, Journal of Inherited Metabolic Disease.

A case of the carbohydrate-deficient glycoprotein syndrome type 1 (CDGS type 1) with normal phosphomannomutase activity

P. Clayton, A. Johnson, B. Winchester, 1997, Journal of Inherited Metabolic Disease.

Defective galactosylation of serum transferrin in galactosemia.

P. Clayton, B. Winchester, J. Charlwood, 1998, Glycobiology.

Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.

P. Clayton, K. Hussain, S. Eaton, 2001, The Journal of clinical investigation.

Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.

R M Winter, R. Winter, J. Burn, 1998, Journal of medical genetics.

Management of idiopathic growth hormone deficient patients during puberty.

P. Clayton, S. Shalet, D. Price, 1988, Acta paediatrica Scandinavica. Supplement.

Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia

P. Gasparini, M. Carella, A. Iolascon, 2005, British journal of haematology.

Liver failure associated with mitochondrial DNA depletion.

S. Love, J. Cooper, A. Schapira, 1998, Journal of hepatology.

Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease.

J. Leonard, A. Aynsley-Green, A. Morris, 1996, Archives of disease in childhood.

Carbohydrate-Deficient Glycoprotein Syndromes: Inborn Errors of Protein Glycosylation

P. Clayton, B. Winchester, G. Keir, 1999, Annals of clinical biochemistry.

Constitutional delay of growth and puberty is not commonly associated with mutations in the acid labile subunit gene.

D. Hanson, P. Clayton, A. Whatmore, 2008, European journal of endocrinology.

The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain

T. Meert, K. Mills, J. Wood, 2015, Neuroscience Letters.

The influence of age, size, pubertal status and renal factors on urinary growth hormone excretion in normal children and adolescents.

G. Addison, P. Clayton, C. Mui, 1992, Growth regulation.

Endocrine status in patients with optic nerve hypoplasia: relationship to midline central nervous system abnormalities and appearance of the hypothalamic-pituitary axis on magnetic resonance imaging.

I. C. Lloyd, P. Clayton, L. Patel, 2003, The Journal of clinical endocrinology and metabolism.

Features of carnitine palmitoyltransferase type I deficiency

P. Clayton, J. Bonham, N. Manning, 2001, Journal of Inherited Metabolic Disease.

Aromatic l-amino acid decarboxylase deficiency

D. Vivo, C. Chiriboga, R. Pons, 2004, Neurology.

Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita

L. Boyes, P. Clayton, G. Besley, 2008, Journal of Medical Genetics.

GROWTH IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKAEMIA

P. Clayton, S. Shalet, P. Morris-Jones, 1988, The Lancet.

Prenatal diagnosis of Smith-Lemli-Opitz syndrome.

K. Mills, D. Donnai, L. Moore, 1995, American journal of medical genetics.

PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?

P. Clayton, P. Lewindon, D. Coman, 2015, JIMD reports.

Demyelination and decreased S‐adenosylmethionine in 5.10‐methylenetetrahydrofolate reductase deficiency

T. Bottiglieri, J. Leonard, U. Wendel, 1988, Neurology.

Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment.

P. Clayton, H. Ichimiya, J. Sjövall, 1991, Journal of lipid research.

The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition.

K. Iyer, P. Clayton, P. Whitfield, 1998, Nutrition.

Dysmorphic syndromes with demonstrable biochemical abnormalities.

P. Clayton, E. Thompson, Peter E. Clayton, 1988, Journal of medical genetics.

Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene.

R. Surtees, T. Flatmark, P. Clayton, 1996, Human molecular genetics.

The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.

S. Ellard, P. Clayton, S. Flanagan, 2011, European journal of endocrinology.

Elevation of plasma aspartylglucosaminidase is a useful marker for the congenital disorders of glycosylation type I (CDG I)

K. Mills, P. Clayton, M. Jackson, 2005, Journal of Inherited Metabolic Disease.

Growth, final height and endocrine sequelae in a UK population of patients with Hurler syndrome (MPS1H)

P. Clayton, N. Robinson, K. Tylee, 2011, Journal of Inherited Metabolic Disease.

A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.

K. Alberti, P. Clayton, M. Thorner, 1993, The Journal of clinical investigation.

Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease.

K. Mills, P. Clayton, M. Casteels, 1993, Gastroenterology.

Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome.

B. Harding, P. Clayton, B. Winchester, 1991, Archives of disease in childhood.

Lack of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase in fibroblasts from a child with urinary excretion of 3 beta-hydroxy-delta 5-bile acids. A new inborn error of metabolism.

P. Clayton, I. Björkhem, J. Sjövall, 1990, The Journal of clinical investigation.

The evolution of spinal growth after irradiation.

P. Clayton, S. Shalet, Peter E. Clayton, 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology.

K. Hyland, P. Clayton, Peter E. Clayton, 1992, Clinical chemistry.

Aromatic amino acid decarboxylase deficiency in twins

K. Hyland, P. Clayton, Peter E. Clayton, 1990, Journal of Inherited Metabolic Disease.

Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome

A. Stevens, P. Clayton, L. Tatò, 2013, The Pharmacogenomics Journal.

The significance of elevated CSF lactate

J. Leonard, M. Cleary, P. Clayton, 2005, Archives of Disease in Childhood.

Female Preponderance in Congenital Adrenal Hyperplasia due to CYP21 Deficiency in England: Implications for Neonatal Screening

M. Coleman, P. Clayton, A. Nordenström, 2005, Hormone Research in Paediatrics.

Inborn errors of bile acid metabolism

P. Clayton, Peter E. Clayton, 1991, Journal of Inherited Metabolic Disease.

Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome

P. Clayton, B. Winchester, G. Keir, 1992, Journal of Inherited Metabolic Disease.